Cyclosporin A and tacrolimus dramatically changed the field of clinical transplantations, and they are also prescribed or currently developed for various autoimmune diseases. They suppress acute allograft rejection effectively, but chronic allograft rejection is a matter of issue on transplantations even when treated with these drugs1), and their dosages are restricted because of their toxicities at high doses. Thus, different effects or safer properties are desirable for the next generation of immunosuppressant drugs. Taking the fact that cyclosporin A and tacrolimus share its mechanism as calcineurin inhibitors into consideration, we screened inhibitors of T-cell activation from microbial products to seek for new immunosuppressants with different mechanism of action and found a potent HDAC (histone deacetylase) inhibitor, FR235222 (1, Fig. 1 ). The isolation and biological properties of 1 are reported in the preceding papers2,3). Herein, structure determination of FR235222 including its absolute stereochemistry will be presented.
FR235222 (1) (1) and its derivatives.
phenylalanine and two acyclic amino acids on the basis of NMR analysis (vide infra). The existence of a benzene, five other sp2 carbons and the proline explain ten unsaturation degrees. Thus, FR235222 should be a macrocyclic compound to account for eleven unsaturation degrees required from its molecular formula. In the 1H-15N HSQC spectrum, three nitrogens observed at 119.6, 132.0 and 129.1ppm respectively correlated with amide protons resonating at 7.52, 5.81 and 7.17ppm. and 4-MePro-aoh (2-H and 11-NH/C-12). NOEs (2-H/34-NH, 31b-H/28-NH, 20-H/16-H2 and 13-H/2-H) agreed to this sequence to give the planar structure of 1 shown in Fig.   3 . The 1H, 13C and 15N NMR assignments of 1 are depicted in Table 1 .
We then focused on stereochemical elucidation of 1. The stereochemistry of the methyl group in 4-MePro proved to be difficult to solve by NMR analysis or chemical degradation, while all attempts to crystallize 1 suitable for X-ray crystallography were in vain. Fortunately, we were grateful to succeed in X-ray analysis of an oxidative derivative 2 ( Fig. 1 ) obtained by treatment of 1 with NaIO4. The crystals of 2 with approximate dimensions of
The structure was determined by a direct method using the program LODEM4). ORTEP drawing of 2 was shown in Table 1 . Analysis of their contribution established the configuration of C-9 to be R.
In conclusion, the whole structure of FR235222 is as shown in Fig. 1, cyclo[- 
FR235222 is composed of L-Phe and three unique amino acids, i.e. a 4-methylproline (4-MePro), an isovaline (iva) and a 2-amino-8-oxo-9-hydroxydecanoic acid (aoh). To the best of our knowledge, the 4-methylproline has been encountered for the first time in tetracyclic peptide chemistry8-16). The isovaline is also a rare amino acid and has been reported only in phoenistatin14) as composites to be mandatory for HDAC inhibition via covalent binding since Yoshida's pioneer work on trapoxin17). We are now under extensive examination of FR235222 derivatives for better pharmacological properties, and the results will be reported in due course.
